| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |